A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder

NCT00206102 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1098

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: quetiapine fumarate
DRUG: risperidone

Sponsor

AstraZeneca